A
ARQT
Arcutis Biotherapeutics, Inc.
31.68
-0.13-0.41%After Hours: 31.66 -0.02 -0.06%19:26 10/27 EDT
OPEN/PREV CLOSE31.40/31.81
TODAY RANGE31.18-32.11
VOL2.22M
MARKET CAP3.98B
52 WEEK RANGE19.30-33.30
AVG VOL (3M)2.49M
% TURNOVER1.18%
TURNOVER--
P/E (TTM)147.69
% RANGE2.93%
EPS(TTM)0.2145
P/E(FORWARD)80.20
P/B18.04
BVPS1.756
DIVIDEND--
P/S10.39
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.52B
SHARES OUTSTANDING125.69M
NEXT EARNINGS10/26-10/30
FREE FLOAT111.19M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·5d ago
Did Raised Sales Guidance Just Shift Arcutis Biotherapeutics (ARQT) Investment Narrative?
Dow Jones·10/19 16:43
Arcutis Biotherapeutics Is Maintained at Buy by Guggenheim
Benzinga·10/19 16:33
Guggenheim Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $44
TipRanks·10/19 13:55
Arcutis Biotherapeutics price target raised to $44 from $38 at Guggenheim
Simply Wall St·10/18 14:25
Arcutis Biotherapeutics (ARQT) Unveiled Fresh ZORYVE Data, Is The Stock Still Below Fair Value?
Dow Jones·10/15 22:38
Arcutis Biotherapeutics Price Target Announced at $48.00/Share by Cantor Fitzgerald
Benzinga·10/15 18:06
Why Is Arcutis Biotherapeutics Stock Surging Thursday?
Seeking Alpha·10/15 16:02
Arcutis jumps as Cantor issues new Overweight citing lead product
TipRanks·10/15 11:15
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald
Simply Wall St·10/11 19:33
ZORYVE Data May Change The Case For Arcutis Biotherapeutics (ARQT)
Simply Wall St·10/10 17:36
Arcutis Biotherapeutics (ARQT) Following Fresh ZORYVE Data Is The Story Fully Valued
Same Industry
Name/Symbol
Change%
Price